Related Tags >> FDA pharmaceuticals antibodies Cancer

immune system News

Most Popular immune system Story

Big Pharma takes an interest in cancer vaccines

September 19, 2007 — 10:49am ET | By Maureen Martino

For two decades, biotech companies have struggled to develop therapeutic cancer vaccines designed to treat the disease by stimulating the immune system to attack cancer cells without harming normal... Read more...

Latest Headlines

IRX Therapeutics raises $25M Series A
June 3, 2008
Antigenics gets world's first cancer vaccine approval
April 8, 2008
Pharming shares sink after Rhucin gets thumbs down
March 20, 2008
Breakthrough reported in flu vaccine research
March 10, 2008
Wyeth takes another look at antibody pact
December 6, 2007
Pfizer buys Coley for $164M
November 16, 2007
SPOTLIGHT: Argos, J&J make a deal
November 16, 2007
Momenta shares tumble after FDA rejection
November 6, 2007
Big Pharma takes an interest in cancer vaccines
September 19, 2007
SPOTLIGHT: Big Pharma takes an interest in cancer vaccines
September 19, 2007
Genmab regains HuMax-CD4 rights
June 29, 2007
Accentia shares soar on cancer trial results
October 19, 2006
Genmab shares up on new antibody tech
October 17, 2006
New research focuses on PD-1's role
August 21, 2006
Congress launches probe of NIH conflicts policies
August 9, 2006
Transplant drugs may offer Type 1 help
March 7, 2006
Researchers tout ricin vaccine data
January 30, 2006
SPOTLIGHT: CellCept wins orphan status
January 3, 2006
SPOTLIGHT: Osiris granted orphan status
December 20, 2005
Cyclacel to go public in reverse merger with Xcyte
December 15, 2005

Paid Research Reports

More Research Reports >>